Key Points
- Kewaunee Scientific CEO Thomas David Hull III sold 629 shares on December 31 at an average price of $37.66 for a total of $23,688.14, leaving him with 35,177 shares valued at $1,324,765.82 (a 1.76% ownership decrease).
- Across late December (Dec. 22–31) he sold a total of 2,542 shares—including 1,000, 884 and 29-share trades—for roughly $97,391 in proceeds.
- Company context: KEQU has a market cap of about $107.6M, a P/E of 9.52, reported quarterly EPS of $0.91 (down from $1.01 year-over-year), and carries a consensus analyst rating of Hold.
Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 629 shares of Kewaunee Scientific stock in a transaction on Wednesday, December 31st. The stock was sold at an average price of $37.66, for a total value of $23,688.14. Following the sale, the chief executive officer owned 35,177 shares in the company, valued at $1,324,765.82. The trade was a 1.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Thomas David Hull III also recently made the following trade(s):
- On Tuesday, December 30th, Thomas David Hull III sold 29 shares of Kewaunee Scientific stock. The stock was sold at an average price of $38.00, for a total transaction of $1,102.00.
- On Monday, December 29th, Thomas David Hull III sold 884 shares of Kewaunee Scientific stock. The stock was sold at an average price of $38.01, for a total value of $33,600.84.
- On Monday, December 22nd, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $39.00, for a total value of $39,000.00.
Kewaunee Scientific Price Performance
Shares of NASDAQ KEQU opened at $37.50 on Friday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.71 and a current ratio of 2.48. Kewaunee Scientific Corporation has a fifty-two week low of $30.33 and a fifty-two week high of $71.33. The stock has a market cap of $107.63 million, a PE ratio of 9.52 and a beta of 0.55. The stock has a fifty day moving average of $39.44 and a 200-day moving average of $46.85.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its earnings results on Wednesday, December 10th. The technology company reported $0.91 EPS for the quarter. Kewaunee Scientific had a return on equity of 22.39% and a net margin of 4.11%.The business had revenue of $70.10 million during the quarter. During the same quarter in the prior year, the business earned $1.01 EPS.
Institutional Investors Weigh In On Kewaunee Scientific
Several institutional investors have recently bought and sold shares of KEQU. Susquehanna International Group LLP purchased a new position in Kewaunee Scientific in the 3rd quarter worth approximately $713,000. Punch & Associates Investment Management Inc. grew its holdings in Kewaunee Scientific by 61.9% in the 3rd quarter. Punch & Associates Investment Management Inc. now owns 70,085 shares of the technology company's stock worth $2,989,000 after acquiring an additional 26,785 shares during the last quarter. Mink Brook Asset Management LLC raised its stake in shares of Kewaunee Scientific by 83.4% during the third quarter. Mink Brook Asset Management LLC now owns 11,571 shares of the technology company's stock valued at $494,000 after acquiring an additional 5,261 shares during the last quarter. Minerva Advisors LLC boosted its holdings in shares of Kewaunee Scientific by 3.7% during the third quarter. Minerva Advisors LLC now owns 80,274 shares of the technology company's stock worth $3,424,000 after purchasing an additional 2,832 shares during the period. Finally, Royce & Associates LP bought a new stake in shares of Kewaunee Scientific in the third quarter worth about $1,663,000. 32.69% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several brokerages have recently commented on KEQU. Weiss Ratings reissued a "hold (c+)" rating on shares of Kewaunee Scientific in a report on Wednesday, October 8th. Wall Street Zen lowered shares of Kewaunee Scientific from a "buy" rating to a "hold" rating in a research report on Saturday, December 13th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company presently has a consensus rating of "Hold".
Get Our Latest Analysis on KEQU
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.
The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
